Gynaecology meets neurology: Paraneoplastic cerebellar degeneration

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 45, Issue 1, 2005, Pages 79-81

  Land, Russell ^a,b   Carter, Jonathan ^a   Houghton, Roger ^a   Atkinson, Ken ^a   Dalrymple, Christopher ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIBODY;

ADULT; ARTICLE; ATAXIA; CASE REPORT; CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DYSARTHRIA; FEMALE; HUMAN; LAPAROSCOPY; MAGNETIC RESONANCE ANGIOGRAPHY; MORTALITY; NAUSEA; NYSTAGMUS; PARANEOPLASTIC NEUROPATHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SPEECH DISORDER; TREMOR; UTERINE TUBE CARCINOMA; VOMITING;

ADENOCARCINOMA; CYSTADENOCARCINOMA, SEROUS; FALLOPIAN TUBE NEOPLASMS; FATAL OUTCOME; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PARANEOPLASTIC CEREBELLAR DEGENERATION;

EID: 15844424826     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2005.00330.x     Document Type: Article

References (20)

1. Ashour AA, Verschraegen CF, Kudelka AP, Kavanagh JJ. Paraneoplastic syndromes of gynecologic neoplasms. J Clin Oncol. 1997; 15: 1272-1282.
2. Santacroce L. Paraneoplastic Syndromes [Internet]. [updated 3 July 2002; cited 16 May 2003]. Available from: http://www.emedicine.com/med/topic1747.htm.
3. Grant R. What the general neurologist needs to know about the paraneoplastic syndromes. Pract Neurol. 2002; 2: 318-324.
4. Bolla L, Palmer RM. Paraneoplastic cerebellar degeneration. Case report and literature review. Arch Intern Med. 1997; 157 1258-1262.
5. Sutton I. Paraneoplastic neurological syndromes. Curr Opin Neurol. 2002; 15: 685-690.
6. Rojas-Marcos I, Rousseau A, Keime-Guibert F et al. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer. Medicine 2003; 82: 216-223.
7. Anderson NE, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol. 1988; 24: 559-567.
8. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003; 349: 1543-1554.
9. Liu S MJ, Berk J, Dalmau J, Posner JB. Expression of Purkinje cell antigens in ovarian tumor and the presence of anti-Purkinje cell antibodies in the serum of patients without paraneoplastic cerebellar degeneration. Neurology 1994; 45: A288-A229.
10. Rojas I, Graus F, Keime-Guibert F et al. Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology 2000; 55: 713-715.
11. Greenlee JE, Brashear HR, Jaeckle KA, Geleris A, Jordan K. Pursuing an occult carcinoma in a patient with subacute cerebellar degeneration and anticerebellar antibodies. Need for vigorous follow-up. West J Med. 1992; 156: 199-202.
12. Shams'ili S, Grefkens J, De Leeuw B et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 2003; 126: 1409-1418.
13. Rosenfeld MR, Dalmau J. Current therapies for paraneoplastic neurologic syndromes. Curr Treat Options Neurol. 2003; 5: 69-77.
14. Perlmutter E, Gregory PC. Rehabilitation treatment options for a patient with paraneoplastic cerebellar degeneration. Am J Phys Med Rehabil. 2003; 82: 158-162.
15. Rees JH, Hain SF, Johnson MR et al. The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders. Brain 2001; 124: 2223-2231.
16. Wilkinson MD, Fulham MJ, Heard RN, McCaughan BC, McCarthy SW. FDG-PET in paraneoplastic neuropathy. Neurology 2003; 60: 1668.
17. Antoine JC, Cinotti L, Tilikete C et al. [18F]fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies. Ann Neurol. 2000; 48: 105-108.
18. Nath U, Grant R. Neurological paraneoplastic syndromes. J Clin Pathol. 1997; 50: 975-980.
19. Kearsley JH, Johnson P, Halmagyi GM. Paraneoplastic cerebellar disease. Remission with excision of the primary tumor. Arch Neurol. 1985; 42: 1208-1210.
20. Albert ML, Austin LM, Darnell RB. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol. 2000; 47: 9-17.